Add Me!Close Menu Navigation

Hedge Fund Law Blog

Add Me!Open Categories Menu

Cleantech: A Viable Option for Hedge Funds and Investors?

By Bart Mallon (www.colefrieman.com)

100 Women in Hedge Funds Hosts Panel of Cleantech Industry Professionals to Discuss the Future of Cleantech Investments

On March 24, 2010, 100 Women in Hedge Funds, a global association of investment management professionals, presented “Is the Grass Really Greener? The Case for Investing in Cleantech”, a networking and educational event focused on the clean technology (“cleantech”) movement and the push for venture capitalists and hedge funds to invest in cleantech technologies. The event, which took place at the Pillsbury Winthrop Shaw Pittman law offices in San Francisco, was host to 100 or so investment management and cleantech professionals from the San Francisco Bay Area who were all noticeably enthusiastic about the evening’s topic.

Kim Tomsen Budinger (of KTB Counsel), who is part of the 100 Women’s Northern California Steering Committee and who co-organized the event with Marianne O (of Lumen Advisors, LLC), introduced the moderator Scott Jacobs, a consultant at McKinsey & Company, and welcomed the following panelists:

  • Richard Bookbinder, Founder of New York-based hedge fund TerraVerde Capital Management LLC
  • Thomas Toy, Co-Founder and Managing Director of Menlo Park-based venture capital firm PacRim Venture Partners
  • Garvin Jabusch, Co-Founder and CIO of Boulder- and Silicon Valley-based investment advisors Green Alpha Advisors, LLC

What is Cleantech?

The discussion started with each of the panelists providing their own definition of cleantech - while each stated that the term is hard to define, it was noted that sectors like water, agriculture, and clean energy fall into the category of cleantech. The panelists also noted that varying definitions of “cleantech” can lead to investor confusion so managers will tend to define “cleantech” through examples of individual companies for instance.* [This confusion actually led to the creation of indicies focused on the sector.]

Despite the challenges of coming to an agreement on a definition, the panelists did express strong optimism about the potential financial growth – cleantech is expected to have revenues of approximately $3 trillion by 2030.  The panelists also discussed cleantech becoming its own sector and reference was made to a November 2009 report by Bank of America/Merrill Lynch entitled “A Stock Analyst’s View of Renewable Energy Technologies”.  The report says that cleantech will be the “sixth technology revolution” (i.e Industrial Revolution, Age of Information and Telecommunications), meaning that the next type of technology the world will operate on will be clean technology from natural resources.

* Cleantech Group LLC, an organization that advises investors and corporations interested in cleantech investing, provides a good overview of cleantech here.

Cleantech Hedge Funds

At a few points during the panel, the discussion went to cleantech hedge funds even though the panelists admitted there are not many cleantech focused hedge funds. Out of a potential universe of say 15,000 global hedge funds, the panelists had only identified around 120 funds focusing on the space. Many of these funds are part of larger hedge fund structures.  For instance, a manager may have a multi-billion dollar flagship fund and then create smaller funds focused on separate strategies or sectors such as cleantech. For many of these managers there is either a personal commitment to renewable energy or demand from mission-based investors (mostly on the high net worth side) for these products.

Of the funds that do focus on cleantech, most will be smaller ($50MM to $200MM) or very small ($10MM to $50MM).  Most of these funds will be either long/short or long only funds. The panel noted that while the cleantech “asset class” is relatively small right now, it is likely to become a larger part of the investing mandate going forward, so we are likely to see an increase (gradually, for right now) in the amount of funds focused on this space.

Challenges for Cleantech – Capital, Management, Government/Regulation

An overriding theme of the discussion was that, as an infant industry in the U.S., Cleantech faces a number various challenges including high capital requirements, relatively inexperienced management teams, and the lack of strong regulatory support.  Together these challenges help to explain why Cleantech in the U.S. is not as developed in other nations like China and Germany.

Perhaps the most difficult issue that the U.S. cleantech industry faces is an ambivalence from Washington and the states.  While some individual states are creating programs aimed to foster investments into cleantech and other earth friendly initiatives (see cap and trade below), at the federal level there are still massively unequal subsidies which are going to older poluting technologies.  In fact, the moderator asked whether the panelists believed that national legislation is “anti-cleantech” (i.e. subsidies to non-cleantech industries show bias toward legacy technologies), but the panelists disagreed.

Obviously consumers will be a driving force toward the allocation of more resources (tax breaks and tax dollars) to the industry even though it is not currently a high priority legislative issue for most Congressmen.  The fact is, however, that the U.S. is lagging other world leaders in cleantech – at several points in the discussion, the panelists made reference to the progress that China and Germany have made in the cleantech in comparison to the U.S. “We [the U.S.] are not at the top of the list”, one panelist said. “The gap is widening between the U.S. and China and Germany. Capital and technology is moving from the US to other countries.” It was noted that the cleantech industry needs to be concentrated domestically but should still have global outreach.

Cleantech Opportunities

Cleantech and institutional demand

One panelist pointed out that there are a number of attractive opportunities and that investors need to be poised to take advantage of these opportunities. Despite the drop in VC investment in the sector in recent years, cleantech remains the number one sector which VCs are allocating to.  (See page 16 of the Bank of America/Merrill Lynch report which contains statistics on venture capital investments in cleantech: http://ww.nrel.gov/analysis/seminar/pdfs/2009/ea_seminar_nov_12_pres.pdf).

While the panelists were optimistic about the future of cleantech, the uncomfortable issue of risk-reward characteristics of investment in the sector was a predominant theme.  Essentially the sector returns (probably) do not justify investment right now because of the numerous risks, as described briefly above.  While more benchmarks are likely to be produced in the future (to appropriately identify those managers who can generate alpha), that will only be the first in a series of metrics which will need to be developed in order to appropriately quantify whether investment in the sector and certain companies is appropriate for investors.  Once the sector is more developed managers are more likely to be able provide the appropriate risk-return metrics to institutional investos, who themselves have to balance risk-return on a portfolio allocation basis.

For some investors, however, risk-return is not part of the investment equation.  Mission-based investors will make investments in the cleantech space because of their belief in the mission of the companies.  These mission-based investors are the groups which are more likely to be the allocating to cleantech managers and VCs at this point in time.

Carbon/Cap and Trade

The panel spent relatively little time discussing carbon and cap and trade systems.  While different from cleantech, carbon emission reduction through a cap and trade system (or systems) may present possibilities for future economic growth and investing and also present attractive potential opportunities for mission-based investors. However, post Copenhagen, it is clear that the major nations will need more time until any kind of comprehensive multi-national treaty is debated and ratified.  Resistance in the U.S. to a federal cap and trade system is keeping the price of carbon extremely low (in the voluntary systems), however Europe has proven that a mandated cap and trade market can work.  Political complexities, both at the national and international level, are likely to stall the development of a U.S. cap and trade regime.  Voluntary markets like the Regional Greenhouse Gas Initiative (RGGI), the Chicago Climate Exchange, and the Western Climate Initiative show that there continues to be strong interest in the cap and trade system.

Conclusion

While the discussion itself was not confined to the subject areas described above, and while the issues surrounding cleantech seem to make it a risky sector to be investing in, the panel and the audience showed great enthusiasm for the subject and the professionals in attendance seemed to feel that this is a sector which is poised for great growth in the future.

****

About Cole-Frieman &  Mallon LLP

Cole-Frieman & Mallon LLP is a San Francisco based law firm focused on the investment management industry. The firm’s services include hedge fund formation, startup services, investment adviser registration, and hedge fund consulting. Additionally, Cole-Frieman & Mallon LLP works with groups in the cleantech and carbon trading space.

Cole-Frieman & Mallon LLP is able to provide the following legal services to both domestic and offshore hedge funds:

  • Offer investment advice to funds interested in the purchase of carbon offsets
  • Provide legal advice to clients in regards to carbon market regulations
  • Assist hedge funds with the creation of investment projects that generate credits and offsets
  • Advise on marketing strategies for those clients interested in selling their carbon offsets or promoting their renewable energy projects
  • Provide networking opportunities with other lawyers engaged in the carbon market field
  • Advise clients on the policies and risks involved with credit trading

For more information, please call Bart Mallon Esq. at 415-868-5345.  Many thanks to Kristina Maalouf for her help with this article.

Posted By Hedge Fund Lawyer

One Response to “Cleantech: A Viable Option for Hedge Funds and Investors?”

Leave a Reply




generic Cytotec fedex no prescription Valacyclovir cod delivery Strattera shipped cash on buy Valtrex online with a debit card order overnight Crestor order overnight Crestor purchase prednisone no visa online without prescription cheap valtrex usa (no prescriptions needed for Buspar|buy Buspar with no prescription|online pharmacies Buspar|Buspar cheap|buy Buspar without rx|purchase rx Buspar without|Buspar purchase online|purchase Buspar online without rx|purchase Buspar free consultation|buy Buspar Online|buy Buspar american express|buy Buspar Online|buy cheap Buspar with dr. prescription|Buspar side effects|fedex Buspar without priscription|overnight Buspar without a rx|order cheap overnight Buspar|Buspar toronto|uk order Buspar|Buspar no doctors prescription|Buspar mexico|Buspar order|no prescription Buspar with fedex|order generic Buspar|buy Buspar without rx from us pharmacy|prezzo Buspar|Buspar 10mg|Buspar from canada|purchasing Buspar without a script|buy Buspar australia|purchase Buspar visa without prescription|online purchase Buspar|buy Buspar no perscription cod|buy Buspar drugs|buy Buspar with visa|buy Buspar without rx needed|buy Buspar without prescription|buy Buspar no prescription low cost|purchase buy Buspar us buy prednisone 10 mg prednisone generic cheapest Orlistat purchase online Premarin pharmacy Cytotec usa buy Valtrex usa buy Valtrex from india where can i buy Cytotec buy generic synthroid online overnight Buy genuine accutane online purchase zithromax cod next day delivery Accutane overnight without rx roaccutane 40 mg online without prescription where can i buy prednisone without a rx prednisone on line accutane without script Zovirax online purchase no rx Orlistat online prednisone where can i buy herbal Orlistat buy genuine Orlistat purchase Cytotec visa cheap Cytotec by money order buy Amitriptyline 75 mg buy Amitriptyline purchase Buspar pay pal without rx finpecia cheap mexican purchase rx finpecia without buy Crestor next day delivery buy Buspar no perscription cod buy herbal valtrex order Crestor without a prescription overnight shipping buy cheap Zithromax purchase Zithromax no visa online without prescription purchase Flomax without rx to ship overnight buy Flomax in india thyroxine without prescription shipped overnight express no prescription Cytotec buy Cytotec online without a prescription buy online xenical without rx buy Accutane online cod buy herbal Accutane Buspar overnight without rx uk Xenical generic buy Flomax with american express buy Premarin pills Premarin without rx medications valtrex price strategy buy Zithromax online no prescription Orlistat overnight no consult valtrex in usa buy Valacyclovir money buy order Accutane pay pal online without rx Crestor uk sales cheap prednisone without a prescription Valtrex overdose prednisone no s consult prednisone without presciption can i get maxalt without a prescription? Orlistat for sale Zithromax order buy discount Flomax us Cytotec without prescription purchase generic prednisone online canadian prescriptions Accutane buy next day valtrex can i get valtrex without a prescription? Valtrex with free dr consultation buy Accutane line no perscription xenical next day Orlistat capsule order Zithromax overnight buy Zithromax no prescription Buspar buy cod Prednisone purchase online 20 mg Prednisone buy Xenical online cheap Flomax overnight without rx Strattera citrate order Flomax overnight delivery purchase xenical without prescription needed best place to buy maxalt online? purchace xenical online purchase Xenical paypal without prescription order generic Valtrex Accutane orderd online without prescription purchase Accutane amex online without rx buy Flomax online cheap generic valtrex no prescription purchase Buspar pay pal online without prescription Valtrex prices how to purchase Valtrex online without rx purchase cheap Xenical xenical online next day shipping Buy xenical without a perscription to ship overnight buy Flomax now purchase xenical cod overnight delivery buy Maxalt 10 mg Tamsulosin buy Crestor rezept cheap Valtrex uk buying Valacyclovir online without rx buy Valtrex pay pal without prescription order overnight Zithromax purchase Bupropion pay pal without rx Amitriptyline fedex Zithromax without rx overnight shipping purchase Orlistat visa without prescription buy Orlistat without doctor where to buy Crestor prednisone no r x cod Buy Cytotec in uk buy Orlistat in the uk buy Valtrex with visa uk buy Prednisone order Buspar pay pal online without rx buy Orlistat visa cheap Cytotec buy Valtrex discount fedex xenical overnight without a prescription xenical without presciption order finpecia no rx Nizoral prices Nizoral pharmacy buy cheap online pharmacy Buspar no prescription Crestor with fedex purchase Flomax no visa without prescription How to get a xenical perscription buy cheap generic Zovirax online where to purchase cheap Prednisone no rx purchase Xenical without rx to ship overnight prednisone over the counter buy prednisone without rx purchase Premarin amex online without rx Buy xenical online cheap where to buy Prednisone online buy Prednisone no prescription Proscar online purchase buy discount Valtrex line valtrex pricing cheap order rx Valtrex Buy prednisone overnight shipping order Prednisone for cash on delivery purchase online prescription Valtrex without Cytotec with no perscription overnight shipping buy prednisone amex online without prescription Zithromax without doctor prescription generic Zithromax prices Valtrex pharmacy pharmacy Valtrex buy Accutane with a mastercard buy Crestor on line amex purchase online prescription finpecia Flomax overnight buy Tamsulosin and Flomax online Orlistat purchase buy Rosuvastatin no rx cheap Crestor usa Generic buspar no prescription buy Flomax australia

Hedge Fund Legal Services

Cole-Frieman & Mallon LLP provides comprehensive legal services for new and existing hedge funds as well as for other investment management companies.

If you are thinking of starting a hedge fund or an incubator fund, please call Bart Mallon of Cole-Frieman & Mallon LLP today at
415-868-5345.

View Bart Mallon's profile on LinkedIn


Recommended Articles

Archives